Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
SAN DIEGO, May 15, 2013 (GLOBE NEWSWIRE) -- Receptos (Nasdaq:RCPT) today announced that Company personnel will deliver three scientific poster presentations about RPC1063 at the Digestive Disease Week (DDW) annual meeting from May 18 to 21, 2013 at the Orange County Convention Center in Orlando, Florida. DDW attracts thousands of physicians, researchers and academics from around the world to share the latest research in gastrointestinal health topics, for which DDW is the premier scientific conference. RPC1063 is the Company’s lead sphingosine 1- phosphate 1 receptor (S1P1R) selective modulator in Phase 2 development for both ulcerative colitis (UC) and relapsing multiple sclerosis (RMS).
Help employers find you! Check out all the jobs and post your resume.
